Gene-modified autologous leukocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gene-modified autologous leukocytes, covering 2012-06-22 to 2012-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]